Over the last few years, the CBD industry has evolved rapidly. What began as a simple choice between low and high strength oils has developed into a far more diverse market, offering different formulations, extraction types, and cannabinoid profiles.
But even with all this progress, one thing remains largely unchanged:
Most people are still choosing CBD products based on general categories, rather than anything truly tailored to them.
That may not always be the case.
As artificial intelligence continues to reshape industries like healthcare, nutrition, and fitness, a new possibility is beginning to emerge – personalised cannabinoid products designed around the individual.
It is still early days, but the idea of custom CBD blends is no longer as far-fetched as it once seemed.
The Rise of Personalisation in Modern Health
Personalisation is already becoming a major trend across multiple industries.
In nutrition, tailored diet plans are now built around individual preferences and data. In fitness, training programmes are adjusted based on performance metrics. Even in skincare, products are being developed to suit specific skin types and conditions.
The common thread is simple:
People no longer want one-size-fits-all solutions.
Instead, they are looking for products that feel relevant to their own needs and routines.
This shift in mindset is beginning to influence how people approach cannabinoids as well.
Why CBD Has Remained Generalised
Despite the broader move towards personalisation, CBD products have largely remained standardised.
Most people choose based on:
- Strength (e.g. 500mg, 1000mg, 2000mg)
- Type (full spectrum, broad spectrum, isolate)
- Format (oil, capsule, edible)
While these factors are important, they do not account for individual differences in how people approach or use CBD products.
This is not due to a lack of interest – it is more a reflection of the limitations that have existed until now.
Creating personalised cannabinoid blends requires a level of data, analysis, and precision that has not traditionally been available at scale.
Where Artificial Intelligence Could Change Everything
Artificial intelligence has already started to transform how data is used in health-related industries.
AI systems can process large amounts of information, identify patterns, and generate insights that would be difficult to uncover manually. This has led to significant advances in areas such as personalised nutrition and predictive health modelling.
When applied to cannabinoids, the same principles could eventually be used to move beyond standardised products.
AI could analyse a range of inputs, such as:
- Usage preferences
- Lifestyle habits
- Product feedback
- General patterns across user data
From there, it could begin to identify which types of cannabinoid profiles tend to align with different types of users.
This does not mean replacing human decision-making, but rather enhancing it with data-driven insight.
Moving Beyond Single-Compound Thinking
One of the key limitations of current CBD products is the focus on single metrics – usually the amount of CBD in a product.
While this provides a useful starting point, it does not reflect the full complexity of the hemp plant.
As discussed in the previous article, cannabinoids exist as part of a broader system that includes multiple compounds. These compounds can vary in concentration, and their relationships with each other are still being explored.
Personalisation would require a shift away from thinking purely in terms of “more CBD” or “less CBD”.
Instead, it would involve considering:
- Different cannabinoid ratios
- The presence of additional compounds
- Variations in formulation
AI could help make sense of this complexity, identifying patterns that are not immediately obvious.
The Idea of Custom Cannabinoid Profiles
In a fully developed personalised system, CBD products might not come in fixed strengths or predefined formulas.
Instead, users could be guided towards specific cannabinoid profiles based on their preferences and behaviour.
For example, rather than choosing between a small number of standard options, someone might be recommended a formulation that includes:
- A specific CBD concentration
- A defined ratio of additional cannabinoids
- A consistent and repeatable profile
While this level of precision is not yet widely available, the building blocks for it are starting to appear.
Data: The Key to Personalisation
For personalisation to work, data is essential.
In other industries, AI-driven systems rely on continuous feedback to improve recommendations over time. The more data they receive, the more accurate they become.
In the context of cannabinoids, this could include:
- Product usage patterns
- Consumer preferences
- Feedback on different formulations
- Broader market trends
As this data grows, AI systems could begin to identify more refined patterns, leading to better-informed suggestions.
This would represent a significant shift from the current approach, where most decisions are based on general guidelines rather than individual insights.
Challenges to Overcome
While the concept of personalised CBD is appealing, there are several challenges that need to be addressed.
First, the science itself is still developing. Although research into cannabinoids is expanding, there is still much to learn about how different compounds interact and how they are best combined.
Second, there are regulatory considerations, particularly in the UK. Any move towards personalised formulations would need to operate within existing frameworks, which place clear limits on how products can be marketed and described.
Third, there is the issue of consistency. Personalised products would need to maintain high standards of quality and repeatability, ensuring that each formulation meets the same level of precision.
Finally, there is the question of accessibility. Advanced systems can be complex, and making them easy to use for everyday consumers will be essential.
The Role of Existing Products
Even as personalisation develops, current CBD products will continue to play an important role.
For many people, starting with established options such as CBD Oil UK products provides a simple and reliable entry point. These products offer consistency, transparency, and a clear structure for understanding strength and formulation.
Personalisation, if it becomes more widespread, is likely to build on this foundation rather than replace it entirely.
A Gradual Evolution
It is important to view this shift as an evolution rather than a sudden change.
The move towards personalised cannabinoid products will not happen overnight. Instead, it will develop gradually as technology improves, data becomes more available, and understanding deepens.
We are already seeing early signs of this progression in other industries, and it is likely that cannabinoids will follow a similar path.
What This Means for the Industry
If personalisation becomes more prominent, it could reshape the CBD industry in several ways.
Brands may move towards:
- More flexible product ranges
- Greater emphasis on data and feedback
- Increased transparency around formulations
- More sophisticated production processes
At the same time, consumers may begin to expect a more tailored experience, moving away from generic products towards something more individual.
Conclusion
The idea of personalised CBD may still be in its early stages, but it reflects a broader shift in how products are developed and used.
As artificial intelligence continues to evolve, it has the potential to bring a new level of precision and insight to cannabinoid products. Rather than relying solely on standardised options, future users may have access to formulations that are shaped by data, patterns, and individual preferences.
For now, CBD remains accessible, consistent, and widely available in familiar formats. But looking ahead, the possibility of custom cannabinoid blends suggests that the industry is far from finished evolving.
And if that evolution continues, the way people choose and use CBD products could become far more personal than it is today.